IperionX Limited

Fundamentals3.0
Price Action6.0
News Sentiment6.0
AI Rating
5.0

Key Drivers

  • Strong cash position
  • Persistent operating losses
  • High valuation

AI
AI Summary

5.0

IPX has re-rated from a speculative science project into a policy-backed U.S. industrial buildout story, but with no revenue, ongoing losses, and a legal/disclosure overhang, the investment case still hinges on visible commercialization and clean reporting before the market can justify the premium—especially if 33.5 support fails.

ExecutionRisk
Legal
IndustrialBuildout‍

Price Chart

Loading chart...

Financial Metrics

-
Revenue (TTM)
-
Net Income (TTM)
-
EPS (Q)
-
MCAP

Deep Analysis

Research tool. Not personalized advice.

Fundamental Analysis

3.0

Key Financial Insights:

  • Strong cash position
  • Persistent operating losses
  • High valuation

IPX has a strong liquidity cushion and low debt, but ongoing losses, negative cash flow, and a rich valuation make the stock fundamentally challenged.

Liquidity
Losses

Price Behavior

6.0
Research tool. Not personalized advice. Technical analysis is for informational purposes only.

Key Price Behavior Insights:

  • Breakout rally
  • Overbought pullback
  • Support watch

IPX is still modestly higher over the last month thanks to a strong late-April breakout to about $41.5, but the sharp pullback since then suggests momentum has cooled and the stock needs to reclaim the $41.3-$41.5 resistance zone to avoid a short-term top.

breakout
pullback
Support Level: $33.5-$33.8
Resistance Level: $41.3-$41.5

Sharp drop from the $41.5 peak after a late-April surge signals near-term overextension

Sentiment & News

6.0

Key News Insights:

  • Supply-chain scale-up
  • Leadership additions
  • Regional expansion

IperionX is scaling U.S. titanium supply-chain capacity amid strong demand and geopolitical tailwinds, while IPX1031 is adding leadership and expanding regional coverage to support growth.

growth
expansion

These updates are modestly positive, pointing to operating momentum at IperionX and a broader market-building strategy at IPX1031